Since the start of May, this stock has corrected almost 30% and made a low of 576. For the first time since the fall, it has ended above the open price on weekly chart. We may see reversal from here on. Overall Pharma space is entering into a bullish zone. Expect stock to go to 630/660/700 with a tight SL of 575. Below 575 we may see 500/530 levels.